These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18187556)

  • 1. Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates.
    Nantermet P; Harada S; Liu Y; Cheng S; Johnson C; Yu Y; Kimme D; Holder D; Hodor P; Phillips R; Ray WJ
    Endocrinology; 2008 Apr; 149(4):1551-61. PubMed ID: 18187556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats.
    Del Bas JM; Fernández-Larrea J; Blay M; Ardèvol A; Salvadó MJ; Arola L; Bladé C
    FASEB J; 2005 Mar; 19(3):479-81. PubMed ID: 15637110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates.
    Amano Y; Shimada M; Miura S; Adachi R; Tozawa R
    Eur J Pharmacol; 2014 Jan; 723():108-15. PubMed ID: 24361308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice.
    Hambruch E; Miyazaki-Anzai S; Hahn U; Matysik S; Boettcher A; Perović-Ottstadt S; Schlüter T; Kinzel O; Krol HD; Deuschle U; Burnet M; Levi M; Schmitz G; Miyazaki M; Kremoser C
    J Pharmacol Exp Ther; 2012 Dec; 343(3):556-67. PubMed ID: 22918042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice.
    Movérare-Skrtic S; Venken K; Andersson N; Lindberg MK; Svensson J; Swanson C; Vanderschueren D; Oscarsson J; Gustafsson JA; Ohlsson C
    Obesity (Silver Spring); 2006 Apr; 14(4):662-72. PubMed ID: 16741268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidyslipidemic effects of a farnesoid X receptor antagonist in primates.
    Amano Y; Shimada M; Miura S; Adachi R; Tozawa R
    Life Sci; 2014 Jun; 106(1-2):25-31. PubMed ID: 24787893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein profile in the male cynomolgus monkey under normal, hypogonadal, and combined androgen blockade conditions.
    Leblanc M; Bélanger MC; Julien P; Tchernof A; Labrie C; Bélanger A; Labrie F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1849-57. PubMed ID: 15070955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
    Nishimoto T; Amano Y; Tozawa R; Ishikawa E; Imura Y; Yukimasa H; Sugiyama Y
    Br J Pharmacol; 2003 Jul; 139(5):911-8. PubMed ID: 12839864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein cholesterol uptake mediates up-regulation of bile-acid synthesis by increasing cholesterol 7alpha-hydroxylase but not sterol 27-hydroxylase gene expression in cultured rat hepatocytes.
    Post SM; Twisk J; van der Fits L; de Wit EC; Hoekman MF; Mager WH; Princen HM
    Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):339-46. PubMed ID: 10393091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein response to 5-alpha-dihydrotestosterone and testosterone in Macaca fascicularis: a hormone-responsive primate model for the study of atherosclerosis.
    Greger NG; Insull W; Probstfield JL; Keenan BS
    Metabolism; 1990 Sep; 39(9):919-24. PubMed ID: 2392061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women.
    Deschênes D; Couture P; Dupont P; Tchernof A
    Obes Res; 2003 Mar; 11(3):469-76. PubMed ID: 12634447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver.
    Matsui S; Yamane T; Takita T; Oishi Y; Kobayashi-Hattori K
    Nutr Res; 2013 Jul; 33(7):580-5. PubMed ID: 23827133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin.
    Gentile MA; Nantermet PV; Vogel RL; Phillips R; Holder D; Hodor P; Cheng C; Dai H; Freedman LP; Ray WJ
    J Mol Endocrinol; 2010 Jan; 44(1):55-73. PubMed ID: 19726620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
    Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
    J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM; Groenendijk M; Solaas K; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
    Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
    J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
    Hansen MK; McVey MJ; White RF; Legos JJ; Brusq JM; Grillot DA; Issandou M; Barone FC
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):196-202. PubMed ID: 20332533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.